Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice

Neuromuscular Disorders

Volumn 7, Issue 8, 1997, Pages 487-492

  Brussee, Valentine ^a   Tardif, François ^a   Tremblay, Jacques P ^a  

^a NONE

Author keywords

Downhill running; Exercise; Mdx mouse; Muscle fiber

Indexed keywords

DYSTROPHIN; EVANS BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXERCISE; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; RUNNING; TREADMILL;

ANIMALS; COLORING AGENTS; EVANS BLUE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE FIBERS; MUSCULAR DYSTROPHY, ANIMAL; PHYSICAL CONDITIONING, ANIMAL; REFERENCE VALUES; RUNNING;

EID: 0031442922     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00115-6     Document Type: Article

References (50)

1. Hoffman E.P., Brown Jr R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
2. Hoffman E.P., Kunkel L.M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 2:1989;1019-1029.
3. Worton R.G. Muscular dystrophies: diseases of dystrophin-glycoprotein complex. Science. 270:1995;755-756.
4. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard M.G., Darlinson M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1989;1578-1580.
5. Bulfield G., Siller W.G., Wight P.A.L., Moore K.J.X. Chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 81:1984;1189-1192.
6. Pastoret C., Sebille A. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve. 18:1995;1147-1154.
7. Stedman H.H., Sweeney H.L., Shrager J.B.et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 352:1991;536-538.
8. Anderson J.E. Dystrophic changes in mdx muscle regenerating from denervation and devascularization. Muscle Nerve. 14:1991;268-279.
9. Grounds MD, Yablonka-Reuveni Z. Molecular and cell biology of skeletal muscle regeneration. In: Partridge T, editor. Molecular and cell biology of muscular dystrophy. London: Chapman and Hall 1993:210-256.
10. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA. 99:1993;3710-3714.
11. Turner P.R., Westwood T., Regan C.M., Steinhardt R.A. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature. 335:1988;735-738.
12. Karpati G., Pouliot Y., Zubrzycka-Gaarn E.et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol. 135:1989;27-32.
13. Partridge T.A. Invited review: myoblasts transfer, a possible therapy for unherited myopathies. Muscle Nerve. 14:1991;197-212.
14. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., Kunkel L.M. Conversion of mdx myofibers from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 337:1989;176-179.
15. Huard J., Verreault S., Roy R., Tremblay M., Tremblay J.P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest. 93:1994;586-599.
16. Morgan J.E., Hoffman E.P., Partridge T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse. J Cell Biol. 111:1990;2437-2449.
17. Vilquin J.T., Wagner E., Kinoshita I., Roy B., Tremblay J.P. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol. 131:1995;975-988.
18. Kinoshita I., Huard J., Tremblay J.P. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve. 17:1994;975-980.
19. Kinoshita I., Roy R., Dugré F.J., Gravel C., Vilquin J.T., Roy B., Goulet M., Asselin I., Tremblay J.P. Myoblast transplantation in monkeys: control of immune response by FK 506. J Neuropath Exp Neurol. 55(6):1996;687-697.
20. Jones DA, Round JM, Skeletal muscle in health and disease. Manchester, New York: Manchester University Press 1990:158-174.
21. Stauber W.T. Eccentric action of muscles: physiology, injury and adaptation. Exerc Sports Sci Rev. 17:1989;157-185.
22. Clarkson P.M., Tremblay I. Exercise-induced muscle damage, repair and adaptation in humans. J Appl Physiol. 65(1):1988;1-6.
23. McNeil P.L., Khakee R. Disruptions of muscle fibers plasma membranes. Role in exercise-induced damage. Am J Pathol. 140(5):1992;1097-1109.
24. Matsuda R., Nishikawa A., Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem. 118:1995;959-964.
25. Coulton G.R., Morgan R.E., Partridge T.A., Sloper J.C. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol. 14:1988;53-70.
26. Cullen M.J., Jaros E. Ultrastructure of the skeletal muscle in the X-chromosome-linked dystrophic (mdx) mouse. Acta Neuropathol. 77:1988;69-81.
27. Weller B., Karpati G., Carpenter S. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci. 100:1990;9-13.
28. Sacco P., Jones D.A., Dick J.R.T., Vrbova G. Contractile properties and susceptibility to exercise induces damage of normal and mdx mouse tibialis anterior muscle. Clin Sci. 82:1992;227-236.
29. Carpenter S., Karpati G. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain. 102:1979;147-161.
30. Armstrong R.B., Ogilvie R.W., Schwane J.A. Eccentric exercise-induced injury to rat skeletal muscle. J Appl Physiol. 54:1983;80-93.
31. Armstrong R.B., Warren G.L., Warren J.A. Mechanisms of exercise-induced muscle fiber injury. Sports Med. 12(3):1991;184-207.
32. Ogilvie R.W., Armstrong R.B., Baird K.E., Bottoms C.L. Lesions in the rat soleus muscle following eccentrically biased exercise. Am J Anat. 182:1988;335-346.
33. Ruddle J.L., Maxwell L.C. Histochemical analysis of diaphragm, soleus and extensor digitorum longus muscles in mdx mice. FASEB J. 5:1991;A1032.
34. Carnwath J.W., Shotton D.M. Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci. 80:1987;39-54.
35. Anderson J.E., Bressler B.H., Owalle W.K. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil. 9:1988;499-515.
36. Balnave C.D., Thompson M.W. Effect of training on eccentric exercise-induced muscle damage. J Appl Physiol. 7564:1993;1545-1551.
37. Nosaka K., Clarkson P.M. Effect of eccentric exercise on plasma enzyme activities previously elevated by eccentric exercise. Eur J Appl Physiol. 69:1994;492-497.
38. McArdle A., Edwards R.H.T., Jackson M.J. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. Clin Sci. 80:1991;367-371.
39. Vilquin JT, Brussee V, Asselin I, Kinoshita I, Gingras, M, Tremblay JP. Evidence of mdx skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 1997 (in press).
40. Edwards R.H.T., Jones D.A., Newham D.A., Chapman S.J. Role of mechanical damage in the pathogenesis of proximal myopathy in man. Lancet. i:1984;548-551.
41. McArdle A., Edwards R.H.T., Jackson M.J. How does dystrophin deficiency lead to muscle degeneration? Evidence from the mdx mouse. Neuromusc Disord. 5(6):1995;445-456.
42. Huard J., Roy R., Guérette B., Verreault S., Tremblay G., Tremblay J.P. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve. 17:1994;224-234.
43. Satoh A., Huard J., Labrecque C., Tremblay J.P. Utilization of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J Histochem Cytochem. 41:1993;1579-1582.
44. Vilquin J.T., Kinoshita I., Roy R., Tremblay J.P. Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse. Neuromusc Disord. 5(6):1995;511-517.
45. Gussoni E., Pavlath G.K., Lanctot A.M., Sharma K., Miller R.G., Steinman L.E., Blau H.M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature (Lond). 356:1992;435-438.
46. Tremblay J.P., Malouin F., Roy R.et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2:1993;99-112.
47. Harris J.B., Johnson M.A. Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake notechis scutatus scutatus. Clin Exp Pharmacol Physiol. 5:1978;587.
48. Fielding R.A., Roger A., Thomas J.et al. Acute response in exercise. III. Neutrophil and IL-1 accumulation in skeletal muscle. Am J Physiol. 265:1993;R166-R172.
49. Palmo J., Asp S., Daugaard J.R., Richter E.A., Klokker M., Pederson B.K. Effect of eccentric exercise on natural killer cell activity. J Appl Physiol. 78(4):1995;1442-1446.
50. Guérette B, Asselin I, Skuk D, Entman M, Tremblay JP. Control of inflammatory damage by anti-LFA-1: increased success of myoblast transplantation. Cell Transplant 1997 (in press).